SYLVIA RUTH PAOLELLO
ATASCADERO, CA
Browse related groups: CA Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$1,647.88
- Category: General Payments
- Program years: PY2022–2024
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $618.76 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $618.76 | 6 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $203.45 | 2 |
| Novo Nordisk AS | $181.62 | 2 |
| Phathom Pharmaceuticals, Inc. | $124.56 | 1 |
| E.R. Squibb & Sons, L.L.C. | $109.13 | 1 |
By program year
Records — PY2024 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096562303 | Novo Nordisk Inc | $93.66 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096565211 | Novo Nordisk Inc | $87.96 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101591543 | E.R. Squibb & Sons, L.L.C. | $109.13 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118267683 | Boehringer Ingelheim Pharmaceuticals, Inc. | $78.46 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118267685 | Boehringer Ingelheim Pharmaceuticals, Inc. | $124.99 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151194865 | Phathom Pharmaceuticals, Inc. | $124.56 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.